Definitive Contract W81XWH17C0025
Award Date 2/28/17
Potential Completion Date 1/26/18
Potential Value $150K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Brooklyn, NY 11217, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
127
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $150,000.00 firm fixed price contract awarded by the U.S. Army Medical Command (MEDCOM) to Sylvatica Biotech Inc., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract provides funding for research and development of a novel cryostasis cocktail and protocol to enable high subzero banking of human organs, building on prior SBIR Phase I work. The contract has a completion date of April 29, 2016 and is designated as a total...
- This is a $1,010,000.00 firm-fixed-price Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Medical Command (MEDCOM) to Sylvatica Biotech Inc., a minority-owned small business. The contract supports further research and development of a novel cryostasis cocktail and protocol to enable high subzero banking of human organs, building upon prior SBIR Phase I work. The contract has a performance period through November 2019 and will be executed in Charleston, South...
- Sylvatica Biotech Inc. has been awarded a $549,604 firm fixed price contract by the Department of the Army Medical Command to further develop a novel cryostasis cocktail and protocol for high subzero banking of human organs under the Small Business Innovation Research Program Phase II Enhancement. The research will build upon Sylvatica's prior Phase I SBIR work to advance organ cryopreservation technology. The total small business set aside contract will be performed in Charleston, South...
- This is a $154,635 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to X-Therma Inc., a minority-owned, woman-owned small business. The contract supports the development of advanced cryoprotectants and their application to the preservation of porcine kidneys ex vivo at subzero temperatures, with the goal of significantly extending the ischemia window of human-sized organs up to 120 hours. This work aligns with...
- This is a $149,999.95 Firm Fixed Price contract awarded by the Defense Medical Command (MEDCOM) to Tissue Testing Technologies LLC, a small disadvantaged business based in North Charleston, South Carolina. The contract is for Phase I of a Small Business Innovation Research (SBIR) program to develop "rapid rewarming reduction of cryoprotectant toxicity and concentration employing magnetic nanoparticles" for organ and tissue preservation. Tissue Testing Technologies has received prior...
- This is a $149,991.20 firm fixed-price SBIR Phase I contract awarded by the U.S. Army Medical Command to X-Therma Inc., a minority-owned, woman-owned small business. The contract is for the development of advanced cryoprotectants and their application to the preservation of porcine kidneys ex vivo at subzero temperatures, with the goal of significantly extending the ischemia window of human-sized organs up to 120 hours. This work is part of X-Therma's broader efforts to advance regenerative...
- This is a $1,009,937.61 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to X-Therma Inc., a minority-owned, woman-owned small business. The contract is for the development of advanced cryoprotectants and their application to the preservation of porcine kidneys ex vivo at sub-zero temperatures, with the goal of significantly extending the ischemia window of human-sized organs up to 120 hours. This work is also supported by additional grants...
- This is a Small Business Innovation Research (SBIR) Phase III contract award from the Department of the Army Medical Command (MEDCOM) to Tissue Testing Technologies LLC, a small disadvantaged business. The $938,441.90 fixed-price level of effort contract is for the further development and optimization of rapid rewarming and cryoprotectant toxicity reduction techniques using magnetic nanoparticles, building on the company's prior SBIR Phase I and II research. The goal is to improve the...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Cell Preservation Services Inc. (CPSI Biotech), a biotechnology company specializing in cryopreservation and thermal ablation technologies. The $149,973.45 Firm Fixed Price contract is for the project "OPTIMAL REWARMING SOLUTIONS FOR CRYOPRESERVED TISSUE SYSTEMS," which aims to develop innovative solutions for cell preservation,...
- This federal contract award W81XWH16C0155 was made by the U.S. Army Medical Command (MEDCOM) to Tissue Testing Technologies LLC, a small disadvantaged business, for the SBIR (Small Business Innovation Research) Phase I project "TISSUE TESTING TECHNOLOGIES". The $149,999.98 fixed-price contract is for research and development related to organ and tissue preservation and banking, with a focus on vitrification techniques and solutions to extend storage times and improve outcomes for...